CLEC7A and neuroblastoma: Nevertheless, its lack of significant toxicity, its potential to bridge innate (CR3) and adaptive (dectin-1) immune mechanisms and its vaccination adjuvant effect provide a scientific basis for incorporating BG into the anti-GD2 immunotherapy strategy for NB.